<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma X</submitter><funding>the Health Commission of Jilin Province</funding><funding>the transverse project</funding><funding>the National Natural Science Foundation of China</funding><pagination>22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12829294</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>Ovarian cancer (OC) remains a highly lethal gynecologic malignancy characterized by substantial molecular heterogeneity and diagnostic challenges. Although many reviews examine specific aspects of OC biology or treatment, few attempt to connect recent findings into a broader and coherent picture. This review provides an integrated and forward-looking synthesis of emerging mechanisms and therapeutic trends in OC, understanding OC progression and therapeutic resistance. Unique contributions of this review include providing a unified interpretation of emerging multi-omics evidence that reshapes the biological understanding of individual OC histotypes, delineating key metabolic dependencies such as glutamine addiction, aberrant lipid remodeling, glycolytic plasticity and purine pathway rewirin</pubmed_abstract><journal>Journal of ovarian research</journal><pubmed_title>Advances in ovarian cancer: biological insights, therapeutic innovations, and future perspectives.</pubmed_title><pmcid>PMC12829294</pmcid><funding_grant_id>No.82160552</funding_grant_id><funding_grant_id>202501-202912</funding_grant_id><funding_grant_id>2024B001</funding_grant_id><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Qu L</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Yu Q</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Advances in ovarian cancer: biological insights, therapeutic innovations, and future perspectives.</name><description>Ovarian cancer (OC) remains a highly lethal gynecologic malignancy characterized by substantial molecular heterogeneity and diagnostic challenges. Although many reviews examine specific aspects of OC biology or treatment, few attempt to connect recent findings into a broader and coherent picture. This review provides an integrated and forward-looking synthesis of emerging mechanisms and therapeutic trends in OC, understanding OC progression and therapeutic resistance. Unique contributions of this review include providing a unified interpretation of emerging multi-omics evidence that reshapes the biological understanding of individual OC histotypes, delineating key metabolic dependencies such as glutamine addiction, aberrant lipid remodeling, glycolytic plasticity and purine pathway rewirin</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-13T05:06:30.439Z</modification><creation>2026-06-13T03:08:41.961Z</creation></dates><accession>S-EPMC12829294</accession><cross_references><pubmed>41354809</pubmed><doi>10.1186/s13048-025-01921-x</doi></cross_references></HashMap>